Clinical Trial: Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Melanoma
Study Type: OBSERVATIONAL
Official Title: Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy
Brief Summary:
Background of the study:Immune checkpoint inhibitors (ICIs) are widely used as treatment for multiple cancer types and the number of patients with longterm disease control after ICIs is increasing.However, the use of ICIs is associated with adverse events (AEs) which can have a negative impact on quality of life (QoL).These AEs include oral manifestations, like alterations in taste and smell, xerostomia, and oral mucosal disorders, and could lead to unwanted weight loss.However, the characteristics of taste and…
Read more